None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Voluntarily agree to participate and sign in informed consent form 2) Women aged 20-65 years 3) BMI: 25kg/m2 = ~ = 35kg/m2
Exclusion criteria
Exclusion criteria: 1) Continuous consumption of antiobesity drugs(absorption inhibitors, antidepressants, anorexing agents), diuretic, contraceptive, steroids, female hormone that affect body weight 2) Continuous consumption of dietary supplement or oriental medicine within 4 weeks before the first visit 3) Consumption of dietary supplement for body weight control or participation in commercial obesity program within 12 weeks before first visit 4) Following diseases: ? Uncontrolled hypertension (=140/90mmHg) ? Diabetes (fasting blood glucose =126 mg/dL) ? Liver dysfunction (AST, ALT = 2.5 times of the upper limit of normal level) ? Renal dysfunction(Creatinine=1.2mg/dL) ? Hyperthiroidism and hypothyroidism ? Malignant tumors 5) Hypersensitivity to vinegar 6) Participation of another clinical trials within 4 weeks before the first visit 7) Pregnant or lactating women 8) Any condition that the principal investigator belives may put the subjects at undue risk
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total abdominal area | — |
Secondary
| Measure | Time frame |
|---|---|
| abdominal visceral and subcutaneous fat area, bady fat and lean body mass, percent body fat, plasma CRP, MCP-1, Adiponectin, leptin, gene expression in adipose tissue;plasma total cholesterol, triglycerol, HDL-cholesterol, LDL-cholesterol, Insulin, HOMA-IR, fasting blood glucose, blood pressure | — |
Countries
Korea, Republic of
Contacts
Ewha Womans University